Skip to content
Search

Latest Stories

Cervical Cancer Prevention Week: It's never too late to book appointment

Cervical cancer screening is a small step that can save lives
Practice Nurse/doctor doing smear test (gettyimages)

‘Cervical cancer screening is a small step that can save lives,’ says TV health expert Thorrun Govind

Cervical cancer is one the most treatable forms of cancer, yet it remains the fourth most common cancer in women.

In observance of Cervical Cancer Prevention Week, pharmacist and TV health expert Thorrun Govind has urged individuals to make sure they attend their cervical cancer screenings.


“Cervical cancer screening is designed to detect early changes in the cells of the cervix before they have a chance to develop into cancer. These changes often have no symptoms, so attending your screening when invited is essential,” said Thorrun, former chair of the Royal Pharmaceutical Society (RPS).

“The procedure is quick and carried out by a trained professional in a private environment. While it may feel a little uncomfortable, it’s a small step that can save lives,” she added.

Thorrun emphasised that if you’ve missed a previous screening, “it is never too late to book an appointment.”

Cervical screening, previously known as a smear test, is offered to women and all people with a cervix aged 25 to 64 as a free NHS health test.

The test screens for human papillomavirus (HPV), which is linked to almost all cervical cancer cases. HPV is a common virus transmitted through sexual contact.

NHS England states, “Cervical screening is not a test for cancer, it's a test to help prevent cancer.”

Many women not up to date with screening

The NHS Cervical Screening Programme England 2023-2024 annual report revealed that over five million individuals were not up to date with their routine check-ups.

The report, published in November 2024, showed that 68.8 per cent of women aged 25 to 64 were screened within the recommended timeframe, slightly up from 68.7 per cent the previous year.

The screening rate was higher among those aged 50 to 64 (74.3 per cent) compared to those aged  25 to 49 ( 66.1per cent).

In 2023-2024, a total of 5.12 million women aged 25 to 64 in England were due for screening.

NHS data shows that only 58 per cent of 25 to 49-year-olds attend cervical screening in London, compared to 70 per cent of 50 to 64-year-olds.

Cervical Cancer Prevention Week  

Cervical Cancer Prevention Week runs from Monday, 20 January until Sunday, 26 January 2025.

The campaign is supported by the four London Cancer Alliances: North Central London Cancer Alliance, South East London Cancer Alliance, North East London Cancer Alliance and RM Partner (NW & SW London) Cancer Alliance.

These alliances are part of the 20 Cancer Alliances established by NHS England to implement the cancer care recommendations in the NHS Long Term Plan.

According to the World Health Organization (WHO), approximately 660,000 women were diagnosed with cervical cancer worldwide in 2022, and around 350,000 women died from the disease.

Although cervical cancer is most commonly diagnosed in women aged 30 to 35, it can occur at any age, and anyone with a cervix is at risk.

Cervical screening and HPV vaccination are the most effective ways to prevent cervical cancer.

NHS has set an ambitious target of eliminating cervical cancer by 2040 by ensuring all eligible individuals have access to HPV vaccination and cervical screening.

More For You

Homecare medicines services face many challenges beyond pharmacy's control

Homecare medicines services face many challenges beyond pharmacy's control

gettyimages

GPhC calls for industry-wide collaboration to strengthen homecare medicines services

The General Pharmaceutical Council (GPhC) has called for industry-wide collaboration to improve homecare medicines services to ensure patients always receive their medicines when needed.

The call follows a recent review by the regulator, which identified several challenges facing homecare services, many of which were beyond the immediate control of the pharmacies providing them.

Keep ReadingShow less
Lack of funding deters NI pharmacy contractors from expanding portfolio

W G Hamilton Pharmacy is the third pharmacy in Northern Ireland to be recently sold to first-time buyers.

Pharmacy ownership trends shift in Northern Ireland due to funding gap

An increasing number of pharmacies in Northern Ireland are being acquired by first-time buyers, as existing contractors and groups pull back from expanding their portfolios amid ongoing funding pressures, according to specialist business property adviser Christie & Co.

Among the most recent sales is W G Hamilton Pharmacy, a busy community pharmacy in Ballysillan, North Belfast.

Keep ReadingShow less
RPS backs Pharmacist Support "Gift in Wills" initiative

The ‘Gift in Wills’ initiative is delivered in partnership with Bequeathed.

Photo credit: gettyimages

Leave a legacy: RPS partners with Pharmacist Support to promote ‘Gift in Wills’

The Royal Pharmaceutical Society (RPS) has announced its support for the ‘Gift in Wills’ initiative run by Pharmacist Support, coinciding with the charity’s birthday celebrations today (Tuesday 15 April).

This collaboration allows RPS members to create a free will while also helping to safeguard the future of vital support services for the pharmacy profession.

Keep ReadingShow less
Pharmacist Support calls for birthday donations to meet rising demand for mental health services

More and more pharmacy professionals are reaching out for help, said Danielle Hunt.

Pharmacist Support's birthday appeal: Donate to address growing mental health demand

Pharmacist Support – the independent charity dedicated to the pharmacy profession – is celebrating 184 years of service with the launch of a special birthday donations appeal.

On 15 April, the charity is urging individuals and organisations across the sector to support its campaign to raise vital funds to meet the increasing demand for its mental health and wellbeing services.

Keep ReadingShow less
Prostate cancer: At-home saliva test could save NHS £500 million annually

PRS saliva test can identify prostate cancer that was missed by an MRI scan

Photo credit: gettyimages

Prostate cancer: Spit test better than blood test in spotting men at highest risk

A simple at-home spit test could help detect prostate cancer earlier, saving the NHS around £500 million a year, according to new research published in the New England Journal of Medicine.

Funded by the National Institute for Health and Care Research (NIHR), the study found that the DNA-based saliva test was more accurate than the current prostate-specific antigen (PSA) blood test in identifying men at risk of developing prostate cancer.

Keep ReadingShow less